Description: Recipharm acquired Arranta Bio, GenIbet and Vibalogics to bolster its biologics offering. Discover more about the newly formed advanced therapies CDMO.
biologics cdmo (10) vibalogics (8) arranta bio (8) genibet (8) advanced therapies cdmo (8)
A cGMP bridge to personalized medicine
GenIbet offers a unique combination of problem-solving attitude and strict GMP compliance crucial for early-stage product development. Based on earlier gained expertise GenIbet provides tailor made solutions for new modalities of biopharmaceuticals.
GenIbet master’s development and manufacturing of Biopharmaceuticals, including Cell and Gene Therapy products, Recombinant proteins, RNA, Live Microbial Products and Vaccines. Biological banks of mammalian and insect cells, bacteria, yeasts and virus are also be provided.